Why orphan drug coverage reimbursement decision-makingneeds patient and public involvement
-
It’s not just big pharma that wants to see IPR reform in US patent legislation – By Richard Lloyd
Pharma Live, , Intellectual Property Rights, 0
For over an hour yesterday, as the Senate Judiciary Committee hearing on the recently introduced PATENT Act unfolded, it seemed like we were...
-
An exploratory analysis of patent fencing in pharmaceuticals: The case of PDE5 inhibitors
Pharma Live, , Intellectual Property Rights, 0
1-s2-0-s0048733312002582-mainDownload
-
Frequently Asked Questions on USPTO
Pharma Live, , Intellectual Property Rights, 0
What XML resources are available at the USPTO to process bulk data? Bulk data uses different versions of XML...
-
Orphan drug market to reach $176bn by 2020 – Courtesy ( PMLiVe)
Pharma Live, , Intellectual Property Rights, 0
pharmacistThe global orphan drug market is expected to account for 19% of all branded prescription drug sales by 2020,...
-
To study the problems faced by innover from conception idea to filling patent in Indian pharmaceutical industry
Pharma Live, , Intellectual Property Rights, 0
1-s2-0-s2212567114002470-mainDownload
-
Amarantus Bioscience Receives Notice Of Allowance For U.S. Patent Application Covering Proprietary Compositions Of Matter And Methods Of Use for manufacture -Courtesy (Biospace)
Pharma Live, , Intellectual Property Rights, 0
SAN FRANCISCO and GENEVA, May 5, 2015 (GLOBE NEWSWIRE) — Amarantus BioScience Holdings, Inc. (OTCQB: AMBS), a biotechnology company focused on...
-
Stempeutics Gets Stem Cell Patent In China (Chinese Application Number: CN201080053627) For Its Novel Stem Cell Drug ‘Stempeucel’ – Courtesy(Biospace)
Pharma Live, , Intellectual Property Rights, 0
Stempeutics Research, a group company of Manipal Education and Medical Group and a Joint Venture with Cipla Group, announced...
-
California Supreme Court Scrutinizes Reverse Payment ANDA Settlements – Courtesy (Pharma Patents)
Pharma Live, , Intellectual Property Rights, 0
POSTED BY COURTENAY C. BRINCKERHOFF ON 12 MAY 2015POSTED IN ANTITRUSTIn In Re Cipro Cases I & II, the California Supreme Court laid...
![](https://ml7mn4k5dnn0.i.optimole.com/w:289/h:289/q:eco/f:best/https://interactivepharm.com/wp-content/uploads/2022/08/Show-your.jpg)